{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:46:26Z","timestamp":1790023586009,"version":"4.0.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.pathol.2016.09.065","type":"journal-article","created":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T16:46:47Z","timestamp":1480524407000},"page":"55-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["BRAF, NRAS, KIT, TERT, GNAQ\/GNA11 mutation profile analysis of head and neck mucosal melanomas: a study of 42 cases"],"prefix":"10.1016","volume":"49","author":[{"given":"\u015eule","family":"\u00d6zt\u00fcrk Sari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130sma\u0130l","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orhun \u00c7i\u011f","family":"Ta\u015fkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u0130zem","family":"Narli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"\u015een","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eenol","family":"\u00c7omo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinar","family":"Firat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u0130lge","family":"B\u0130lg\u0130\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u0130lek","family":"Yilmazbayhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasem\u0130n","family":"\u00d6zl\u00fck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nes\u0130m\u0130","family":"B\u00fcy\u00fckbaban\u0130","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2016.09.065_bib1","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G","article-title":"The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society","volume":"83","author":"Chang","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.pathol.2016.09.065_bib2","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/cncr.20866","article-title":"Incidence of noncutaneous melanomas in the US","volume":"103","author":"McLaughlin","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.pathol.2016.09.065_bib3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/hed.10019","article-title":"Primary mucosal malignant melanoma of the head and neck","volume":"24","author":"Patel","year":"2002","journal-title":"Head Neck"},{"key":"10.1016\/j.pathol.2016.09.065_bib4","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/hed.20878","article-title":"Mucosal melanomas of the head and neck: experience of the Princess Margaret Hospital","volume":"30","author":"Bachar","year":"2008","journal-title":"Head Neck"},{"key":"10.1016\/j.pathol.2016.09.065_bib5","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1245\/s10434-011-1685-4","article-title":"Predictors of survival in mucosal melanoma of the head and neck","volume":"18","author":"Jethanamest","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.pathol.2016.09.065_bib6","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.oraloncology.2008.01.014","article-title":"Primary mucosal melanoma of the head and neck. Comparison of clinical presentation and histopathologic features of oral and sinonasal melanoma","volume":"44","author":"McLean","year":"2008","journal-title":"Oral Oncol"},{"key":"10.1016\/j.pathol.2016.09.065_bib7","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3109\/0284186X.2016.1143117","article-title":"Primary mucosal melanoma of the head and neck in Denmark, 1982-2012: Demographic and clinical aspects. A retrospective DAHANCA study","volume":"55","author":"Lawaetz","year":"2016","journal-title":"Acta Oncol"},{"key":"10.1016\/j.pathol.2016.09.065_bib8","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2016.09.065_bib9","unstructured":"National Comprehensive Cancer Network. Clinical Guidelines in Oncology: Melanoma (Version 2.2016). Cited 24 June 2016. https:\/\/www.nccn.org\/store\/login\/login.aspx?ReturnURL=https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/melanoma.pdf."},{"key":"10.1016\/j.pathol.2016.09.065_bib10","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/DAD.0000000000000035","article-title":"Head and neck mucosal melanoma: a review","volume":"36","author":"Lourenco","year":"2014","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.pathol.2016.09.065_bib11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s11912-012-0244-x","article-title":"Mucosal melanoma: pathogenesis, clinical behavior, and management","volume":"14","author":"Postow","year":"2012","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.pathol.2016.09.065_bib12","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jaad.2014.03.031","article-title":"Update on primary mucosal melanoma","volume":"71","author":"Tacastacas","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.pathol.2016.09.065_bib13","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa050092","article-title":"Distinct sets of genetic alterations in melanoma","volume":"353","author":"Curtin","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2016.09.065_bib14","first-page":"6483","article-title":"NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression","volume":"9","author":"Omholt","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2016.09.065_bib15","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1038\/onc.2012.345","article-title":"MAP kinase signaling and inhibition in melanoma","volume":"32","author":"Sullivan","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.pathol.2016.09.065_bib16","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.pathol.2015.12.010","article-title":"Targeted therapies and immune checkpoint inhibitors in the treatment of metastatic melanoma patients: a guide and update for pathologists","volume":"48","author":"Kakavand","year":"2016","journal-title":"Pathology"},{"key":"10.1016\/j.pathol.2016.09.065_bib17","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1365-2133.2010.10185.x","article-title":"Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis","volume":"164","author":"Lee","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.pathol.2016.09.065_bib18","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2016.09.065_bib19","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0140-6736(12)60868-X","article-title":"Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial","volume":"380","author":"Hauschild","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.pathol.2016.09.065_bib20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(13)70024-X","article-title":"MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study","volume":"14","author":"Ascierto","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.pathol.2016.09.065_bib21","first-page":"783","article-title":"NRAS and BRAF mutation frequency in primary oral mucosal melanoma","volume":"26","author":"Buery","year":"2011","journal-title":"Oncol Rep"},{"key":"10.1016\/j.pathol.2016.09.065_bib22","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.humpath.2013.01.025","article-title":"Oncogene abnormalities in a series of primary melanomas of the sinonasal tract: NRAS mutations and cyclin D1 amplification are more frequent than KIT or BRAF mutations","volume":"44","author":"Chraybi","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2016.09.065_bib23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/jop.12358","article-title":"Mutation scanning of BRAF, NRAS, KIT, and GNAQ\/GNA11 in oral mucosal melanoma: a study of 57 cases","volume":"45","author":"Lyu","year":"2016","journal-title":"J\u00a0Oral Pathol Med"},{"key":"10.1016\/j.pathol.2016.09.065_bib24","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1158\/1078-0432.CCR-10-2917","article-title":"KIT pathway alterations in mucosal melanomas of the vulva and other sites","volume":"17","author":"Omholt","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2016.09.065_bib25","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hed.23079","article-title":"Sinonasal mucosal melanoma: Molecular profile and therapeutic implications from a series of 32 cases","volume":"35","author":"Turri-Zanoni","year":"2013","journal-title":"Head Neck"},{"key":"10.1016\/j.pathol.2016.09.065_bib26","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/bjc.2013.373","article-title":"KIT, NRAS and BRAF mutations in sinonasal mucosal melanoma: a study of 56 cases","volume":"109","author":"Zebary","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pathol.2016.09.065_bib27","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1200\/JCO.2010.33.9275","article-title":"Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification","volume":"29","author":"Guo","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2016.09.065_bib28","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1200\/JCO.2012.47.7836","article-title":"Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin","volume":"31","author":"Hodi","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2016.09.065_bib29","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1001\/jama.2011.746","article-title":"KIT as a therapeutic target in metastatic melanoma","volume":"305","author":"Carvajal","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.pathol.2016.09.065_bib30","doi-asserted-by":"crossref","first-page":"6821","DOI":"10.1158\/1078-0432.CCR-08-0575","article-title":"KIT gene mutations and copy number in melanoma subtypes","volume":"14","author":"Beadling","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2016.09.065_bib31","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1200\/JCO.2006.06.2984","article-title":"Somatic activation of KIT in distinct subtypes of melanoma","volume":"24","author":"Curtin","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2016.09.065_bib32","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1158\/1078-0432.CCR-11-1987","article-title":"Sunitinib therapy for melanoma patients with KIT mutations","volume":"18","author":"Minor","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2016.09.065_bib33","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000350683","article-title":"Unexpected distribution of cKIT and BRAF mutations among southern Italian patients with sinonasal melanoma","volume":"226","author":"Colombino","year":"2013","journal-title":"Dermatology"},{"key":"10.1016\/j.pathol.2016.09.065_bib34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00428-007-0524-2","article-title":"C-kit protein expression correlated with activating mutations in KIT gene in oral mucosal melanoma","volume":"452","author":"Rivera","year":"2008","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2016.09.065_bib35","doi-asserted-by":"crossref","first-page":"dju246","DOI":"10.1093\/jnci\/dju246","article-title":"TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma","volume":"106","author":"Griewank","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.pathol.2016.09.065_bib36","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1230062","article-title":"TERT promoter mutations in familial and sporadic melanoma","volume":"339","author":"Horn","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.pathol.2016.09.065_bib37","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1126\/science.1229259","article-title":"Highly recurrent TERT promoter mutations in human melanoma","volume":"339","author":"Huang","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.pathol.2016.09.065_bib38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/CMR.0000000000000048","article-title":"Melanomas of unknown primary frequently harbor TERT-promoter mutations","volume":"24","author":"Egberts","year":"2014","journal-title":"Melanoma Res"},{"key":"10.1016\/j.pathol.2016.09.065_bib39","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/CMR.0000000000000148","article-title":"TERT promoter mutations in sinonasal malignant melanoma: a study of 49 cases","volume":"25","author":"Jangard","year":"2015","journal-title":"Melanoma Res"},{"key":"10.1016\/j.pathol.2016.09.065_bib40","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1016\/j.oraloncology.2015.05.009","article-title":"TERT promoter mutation is absent in oral mucosal melanoma","volume":"51","author":"Miao","year":"2015","journal-title":"Oral Oncol"},{"key":"10.1016\/j.pathol.2016.09.065_bib41","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nature07586","article-title":"Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi","volume":"457","author":"Van Raamsdonk","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2016.09.065_bib42","doi-asserted-by":"crossref","first-page":"4724","DOI":"10.1038\/onc.2013.418","article-title":"Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations","volume":"33","author":"Chen","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.pathol.2016.09.065_bib43","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1186\/1471-2407-14-516","article-title":"GNAQ mutation in a patient with metastatic mucosal melanoma","volume":"14","author":"Kim","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.pathol.2016.09.065_bib44","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0002-9610(70)80001-0","article-title":"Malignant melanoma of the skin of the head and neck. An analysis of 405 cases","volume":"120","author":"Ballantyne","year":"1970","journal-title":"Am J Surg"},{"key":"10.1016\/j.pathol.2016.09.065_bib45","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00428-015-1851-3","article-title":"Molecular alterations in malignant blue nevi and related blue lesions","volume":"467","author":"Yilmaz","year":"2015","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2016.09.065_bib46","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12022-016-9420-0","article-title":"Classic architecture with multicentricity and local recurrence, and absence of TERT promoter mutations are correlates of BRAF (V600E) harboring pediatric papillary thyroid carcinomas","volume":"27","author":"Onder","year":"2016","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.pathol.2016.09.065_bib47","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000441444","article-title":"Noncutaneous melanomas: a single-center analysis","volume":"232","author":"Del Prete","year":"2016","journal-title":"Dermatology"},{"key":"10.1016\/j.pathol.2016.09.065_bib48","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.molonc.2007.12.003","article-title":"Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site","volume":"1","author":"Platz","year":"2008","journal-title":"Mol Oncol"},{"key":"10.1016\/j.pathol.2016.09.065_bib49","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/jclinpath-2014-202572","article-title":"KIT genetic alterations in anorectal melanomas","volume":"68","author":"Santi","year":"2015","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.pathol.2016.09.065_bib50","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00428-014-1608-4","article-title":"Telomerase promoter mutations in cancer: an emerging molecular biomarker?","volume":"465","author":"Vinagre","year":"2014","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2016.09.065_bib51","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.otohns.2007.12.013","article-title":"Sinonasal melanoma: a clinicopathologic review of 61 cases","volume":"138","author":"Dauer","year":"2008","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.pathol.2016.09.065_bib52","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1002\/cncr.24976","article-title":"Mucosal melanoma of the nose and paranasal sinuses, a contemporary experience from the MD Anderson Cancer Center","volume":"116","author":"Moreno","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.pathol.2016.09.065_bib53","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1158\/1078-0432.CCR-03-0562","article-title":"Exon 15 BRAF mutations are uncommon in melanomas arising in nonsun-exposed sites","volume":"10","author":"Cohen","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2016.09.065_bib54","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/sj.bjc.6605635","article-title":"Clinical responses observed with imatinib or sorafenib in melanoma patients expressing mutations in KIT","volume":"102","author":"Handolias","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pathol.2016.09.065_bib55","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.ejca.2012.02.049","article-title":"Sinonasal, genital and acrolentiginous melanomas show distinct characteristics of KIT expression and mutations","volume":"48","author":"Schoenewolf","year":"2012","journal-title":"Eur J Cancer"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516403545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516403545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T22:14:23Z","timestamp":1718921663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302516403545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0031302516403545"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2016.09.065","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BRAF, NRAS, KIT, TERT, GNAQ\/GNA11 mutation profile analysis of head and neck mucosal melanomas: a study of 42 cases","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2016.09.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}